Children's Healthcare of Atlanta Cardiology, Department of Pediatrics, Emory University, 1405 Clifton Rd NE, Atlanta, GA, 30322, USA.
The Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta and the Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Curr Cardiol Rep. 2023 Oct;25(10):1327-1335. doi: 10.1007/s11886-023-01950-2. Epub 2023 Sep 9.
Cardiovascular (CV) disease is a known complication of SARS-CoV-2 infection. A clear benefit of COVID-19 vaccination is a reduction mortality; however, COVID-19 vaccination may also prevent cardiovascular disease (CVD). We aim to describe CV pathology associated with SARS-CoV-2 infection and describe how COVID-19 vaccination is a strategy for CVD prevention.
The risks and benefits of COVID-19 vaccination have been widely studied. Analysis of individuals with and without pre-existing CVD has shown that COVID-19 vaccination can prevent morbidity associated with SARS-CoV-2 infection and reduce mortality. COVID-19 vaccination is effective in preventing myocardial infarction, cerebrovascular events, myopericarditis, and long COVID, all associated with CVD risk factors. Vaccination reduces mortality in patients with pre-existing CVD. Further study investigating ideal vaccination schedules for individuals with CVD should be undertaken to protect this vulnerable group and address new risks from variants of concern.
心血管疾病是 SARS-CoV-2 感染的已知并发症。COVID-19 疫苗接种的明显益处是降低死亡率；然而，COVID-19 疫苗接种也可能预防心血管疾病（CVD）。我们旨在描述与 SARS-CoV-2 感染相关的 CV 病理学，并描述 COVID-19 疫苗接种如何成为 CVD 预防策略。
COVID-19 疫苗接种的风险和益处已得到广泛研究。对有和没有预先存在的 CVD 的个体进行的分析表明，COVID-19 疫苗接种可以预防与 SARS-CoV-2 感染相关的发病率，并降低死亡率。COVID-19 疫苗接种可有效预防与 CVD 风险因素相关的心肌梗死、脑血管事件、心肌炎和长 COVID。疫苗接种降低了患有预先存在的 CVD 的患者的死亡率。应进一步研究针对 CVD 患者的理想疫苗接种方案，以保护这一脆弱群体，并应对来自关注变种的新风险。
